Table 5.
N | n (%) | |
---|---|---|
Episode management | 322 | |
Class I antiarrhythmicsa | 26 (8.0) | |
Class III antiarrhythmicsb | 120 (37.0) | |
Direct current cardioversion | 122 (38.0) | |
Antiarrhythmic drugs at last follow-up | 322 | |
Class I antiarrhythmicsa | 7 (2.0) | |
Class III antiarrhythmicsb | 51 (16.0) | |
Percutaneous catheter ablation | 322 | |
Atrial fibrillation | 9 (3.0) | |
Intra-atrial re-entrant tachycardia | ||
Typical atrial flutter | 67 (21.0) | |
Atypical right atrial flutter | 45 (14.0) | |
Atypical left atrial flutter | 1 (0.3) | |
Focal atrial tachycardia | 14 (4.0) | |
Antiarrhythmic surgery | 322 | |
Right atrial Maze | 121 (38.0) | |
Left atrial Maze | 1 (0.3) | |
Biatrial Maze | 25 (8.0) |
’N’ signifies number of patients with available data and ‘n’ signifies number of patients with positive results for each variable.
Quinidine, procainamide, flecainide, propafenone.
Sotalol, dofetilide, amiodarone.